Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The investigators hypothesize that chemoreflex response of muscle sympathetic nerve activity (MSNA) during hypoxia and hypercapnia will be increased in coronary artery disease (CAD) patients and that the presence of obstructive sleep apnea (OSA) will potentiate these responses. And, that the exercise training would decrease the chemoreflex response of MSNA in these patients.
Forty patients with coronary artery disease, with (n=20) and without (n=20) obstructive sleep apnea will be studied. A healthy control, age-paired group (n=10) will be also evaluated. The patients will be submitted to a polysomnography and randomized for clinical follow-up or exercise training for four months. It will evaluated the autonomic function, chemoreflex control of sympathetic activity during hypoxic and hypercapnic maneuvers, endothelial function and inflammatory markers.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Control Group | No Intervention | Healthy control group for comparisons with coronary artery disease groups. | |
| CAD without OSA - Control | No Intervention | Clinical follow-up. | |
| CAD without OSA - Intervention | Experimental | Aerobic exercise training. |
|
| CAD with OSA - Control | No Intervention | Clinical follow-up. | |
| CAD with OSA - Intervention | Experimental | Aerobic exercise training. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Aerobic exercise training | Other | The patients will be submitted to four months of aerobic exercise training, three time a week. |
|
| Measure | Description | Time Frame |
|---|---|---|
| Chemoreflex control of MSNA at rest and during exercise. | Chemoreflex control of MSNA will be measured by microneurography technique during the gas mixture known exposure at rest and during exercise | baseline and after 4 months |
| Measure | Description | Time Frame |
|---|---|---|
| Endothelial Function | Endothelial Function will be measured by markers present in blood samples. | baseline and after 4 months |
| Neurovascular Control | Neurovascular Control will be measured by venous occlusion plethysmography technique during the exposure mixture of gases known at rest and during exercise. |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Maria Urbana PB Rondon, PhD | Contact | 55 11 30918784 | urbana@usp.br | |
| Carlos Alcino do Nascimento Filho, BS | Contact | 55 1126615099 | carlosalcinofilho@yahoo.com.br |
| Name | Affiliation | Role |
|---|---|---|
| Maria Urbana PB Rondon, PhD | University of Sao Paulo | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Heart Institute (InCor) - University of Sao Paulo | Recruiting | São Paulo | 05403-900 | Brazil |
Not provided
| ID | Term |
|---|---|
| D003324 | Coronary Artery Disease |
| D020181 | Sleep Apnea, Obstructive |
| D009043 | Motor Activity |
| ID | Term |
|---|---|
| D003327 | Coronary Disease |
| D017202 | Myocardial Ischemia |
| D006331 | Heart Diseases |
| D002318 | Cardiovascular Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| baseline and after 4 months |
| Inflammatory markers | Inflammatory markers will be measured by markers present in blood samples. | baseline and after 4 months |
| Quality of Life | Quality of life will be measured by the questionnaire Short-Form Health Survey (SF-36). | baseline and after 4 months |
| Anxiety Trait and State | Anxiety Trait and State will be measured by the Spielberger state trait anxiety inventory (STAI). | baseline and after 4 months |
| Symptoms of Depression | The level of symptoms of depression will be measured by the Beck scale. | baseline and after 4 months |
| Mood State | Mood State will be measured by the profile of mood states (POMS) scale. | baseline and after 4 months |
| D001161 |
| Arteriosclerosis |
| D001157 | Arterial Occlusive Diseases |
| D014652 | Vascular Diseases |
| D012891 | Sleep Apnea Syndromes |
| D001049 | Apnea |
| D012120 | Respiration Disorders |
| D012140 | Respiratory Tract Diseases |
| D020919 | Sleep Disorders, Intrinsic |
| D020920 | Dyssomnias |
| D012893 | Sleep Wake Disorders |
| D009422 | Nervous System Diseases |
| D001519 | Behavior |